{"id":3193,"date":"2017-09-26T14:59:30","date_gmt":"2017-09-26T14:59:30","guid":{"rendered":"http:\/\/192.168.32.60\/?page_id=3193"},"modified":"2025-10-27T22:38:02","modified_gmt":"2025-10-27T19:08:02","slug":"tetrabenazin-2","status":"publish","type":"page","link":"https:\/\/www.alhavipharma.com\/en\/tetrabenazin-2\/","title":{"rendered":"tetrabenazin"},"content":{"rendered":"<section class=\"l-section wpb_row us_custom_b91424ac height_medium\"><div class=\"l-section-h i-cf\"><div class=\"g-cols vc_row via_grid cols_7-5 laptops-cols_inherit tablets-cols_inherit mobiles-cols_1 valign_top type_default stacking_default\"><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"g-cols wpb_row via_grid cols_1 laptops-cols_inherit tablets-cols_inherit mobiles-cols_1 valign_top type_default stacking_default\"><div class=\"wpb_column vc_column_container us_custom_72fc42ef\"><div class=\"vc_column-inner\"><\/div><\/div><\/div>[vc_custom_heading text=&#8221;Tetrabenazine&#8221; font_container=&#8221;tag:h1|text_align:left&#8221; use_theme_fonts=&#8221;yes&#8221; css=&#8221;.vc_custom_1730040002{margin-bottom:12px !important;}&#8221;]<div class=\"wpb_text_column us_custom_3725e9ff\"><div class=\"wpb_wrapper\"><p>Tetrabenazine is a vesicular monoamine transporter 2 (VMAT2) inhibitor produced by Alhavi Pharmaceutical.<br \/>\nIt is used to reduce involuntary (choreiform) movements associated with Huntington\u2019s disease by decreasing dopamine levels in the brain.<br \/>\nTetrabenazine also helps control tardive dyskinesia caused by prolonged use of antipsychotic medications.<br \/>\nTreatment must be carried out under strict medical supervision, with regular monitoring of neurological and psychiatric side effects.<\/p>\n<\/div><\/div><div class=\"wpb_text_column us_custom_6e987a3d\"><div class=\"wpb_wrapper\"><p>Dosage form: Tablet<\/p>\n<\/div><\/div><\/div><\/div><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"w-image align_none\"><div url class=\"w-image-h\"><img loading=\"lazy\" decoding=\"async\" width=\"498\" height=\"311\" src=\"https:\/\/www.alhavipharma.com\/en\/wp-content\/uploads\/2017\/09\/Tetrabenazine-25-En.jpg\" class=\"attachment-large size-large\" alt=\"\" srcset=\"https:\/\/www.alhavipharma.com\/en\/wp-content\/uploads\/2017\/09\/Tetrabenazine-25-En.jpg 498w, https:\/\/www.alhavipharma.com\/en\/wp-content\/uploads\/2017\/09\/Tetrabenazine-25-En-300x187.jpg 300w\" sizes=\"auto, (max-width: 498px) 100vw, 498px\" \/><\/div><\/div><\/div><\/div><\/div><\/div><\/section><section class=\"l-section wpb_row us_custom_6217dcc9 height_medium\"><div class=\"l-section-h i-cf\"><div class=\"g-cols vc_row via_grid cols_1 laptops-cols_inherit tablets-cols_inherit mobiles-cols_1 valign_top type_default stacking_default\"><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"w-tabs us_custom_00310b13 layout_hor style_default switch_click has_scrolling\" style=\"--sections-title-size:1em\"><div class=\"w-tabs-list items_2 align_none\"><div class=\"w-tabs-list-h\"><button class=\"w-tabs-item active\" aria-controls=\"content-t0b0\" aria-expanded=\"false\"><span class=\"w-tabs-item-title\">Overview<\/span><\/button><button class=\"w-tabs-item\" aria-controls=\"content-c3dd\" aria-expanded=\"false\"><span class=\"w-tabs-item-title\">Directions for Use<\/span><\/button><\/div><\/div><div class=\"w-tabs-sections titles-align_none icon_chevron cpos_right\"><div class=\"w-tabs-section active\" id=\"t0b0\"><button class=\"w-tabs-section-header active\" aria-controls=\"content-t0b0\" aria-expanded=\"true\"><div class=\"w-tabs-section-title\">Overview<\/div><div class=\"w-tabs-section-control\"><\/div><\/button><div  class=\"w-tabs-section-content\" id=\"content-t0b0\"><div class=\"w-tabs-section-content-h i-cf\"><div class=\"wpb_text_column us_custom_bfe97582\"><div class=\"wpb_wrapper\"><p>Tetrabenazine is indicated for:<br \/>\n\u2022 Treatment of involuntary movements (chorea) associated with Huntington\u2019s disease<br \/>\n\u2022 Management of tardive dyskinesia caused by antipsychotic medications<br \/>\nTetrabenazine works by inhibiting VMAT2, reducing dopamine and serotonin storage in nerve terminals, and decreasing excessive motor activity.<\/p>\n<\/div><\/div><\/div><\/div><\/div><div class=\"w-tabs-section\" id=\"c3dd\"><button class=\"w-tabs-section-header\" aria-controls=\"content-c3dd\" aria-expanded=\"false\"><div class=\"w-tabs-section-title\">Directions for Use<\/div><div class=\"w-tabs-section-control\"><\/div><\/button><div  class=\"w-tabs-section-content\" id=\"content-c3dd\"><div class=\"w-tabs-section-content-h i-cf\"><div class=\"wpb_text_column us_custom_bf054df1\"><div class=\"wpb_wrapper\"><p>\u2022 Initial dose: 12.5\u201325 mg per day (gradually increased under medical supervision)<br \/>\n\u2022 Take with food to minimize gastrointestinal side effects<br \/>\n\u2022 Regular monitoring of neurological and psychiatric symptoms is essential<br \/>\n\u2022 Do not stop the medication abruptly without consulting your doctor<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/section>\n","protected":false},"excerpt":{"rendered":"[vc_custom_heading text=\"Tetrabenazine\" font_container=\"tag:h1|text_align:left\" use_theme_fonts=\"yes\" css=\".vc_custom_1730040002{margin-bottom:12px !important;}\"]Tetrabenazine is a vesicular monoamine transporter 2 (VMAT2) inhibitor produced by Alhavi Pharmaceutical. It is used to reduce involuntary (choreiform) movements associated with Huntington\u2019s disease by decreasing dopamine levels in the brain. Tetrabenazine also helps control tardive dyskinesia caused by prolonged use of antipsychotic medications. Treatment must be carried out...","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"class_list":["post-3193","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.alhavipharma.com\/en\/wp-json\/wp\/v2\/pages\/3193","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.alhavipharma.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.alhavipharma.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.alhavipharma.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.alhavipharma.com\/en\/wp-json\/wp\/v2\/comments?post=3193"}],"version-history":[{"count":8,"href":"https:\/\/www.alhavipharma.com\/en\/wp-json\/wp\/v2\/pages\/3193\/revisions"}],"predecessor-version":[{"id":6177,"href":"https:\/\/www.alhavipharma.com\/en\/wp-json\/wp\/v2\/pages\/3193\/revisions\/6177"}],"wp:attachment":[{"href":"https:\/\/www.alhavipharma.com\/en\/wp-json\/wp\/v2\/media?parent=3193"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}